PHOSPHORYLATION OF WILDTYPE KLF6 BY GSK3β, BUT NOT OF HCC-DERIVED KLF6 MUTANTS, ENHANCES ITS TRANSCRIPTIONAL ACTIVITY

被引：0
|
作者：
Lee, Ursula E. [1 ]
Cheng, George Z. [1 ]
Ghiassi-Nejad, Zahra [1 ]
Munoz-Moron, Ursula [1 ]
Vetter, Diana [1 ]
Hannivoort, Rebekka A. [1 ]
Friedman, Scott L. [1 ]
机构：
[1] Mt Sinai Hosp, New York, NY 10029 USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
101
引用
收藏
页码：370A / 370A
页数：1
相关论文
共 50 条
  • [1] GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21
    U E Lang
    P Kocabayoglu
    G Z Cheng
    Z Ghiassi-Nejad
    U Muñoz
    D Vetter
    D A Eckstein
    R A Hannivoort
    M J Walsh
    S L Friedman
    Oncogene, 2013, 32 : 4557 - 4564
  • [2] GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21
    Lang, U. E.
    Kocabayoglu, P.
    Cheng, G. Z.
    Ghiassi-Nejad, Z.
    Munoz, U.
    Vetter, D.
    Eckstein, D. A.
    Hannivoort, R. A.
    Walsh, M. J.
    Friedman, S. L.
    ONCOGENE, 2013, 32 (38) : 4557 - 4564
  • [3] Activation of KLF6 by titanate nanofibers and regulatory roles of KLF6 on ATF3 in the endothelial monolayer and mouse aortas
    Song, Fengmei
    Li, Shuang
    Dai, Xuyan
    Yang, Fei
    Cao, Yi
    MOLECULAR OMICS, 2023, 19 (02) : 150 - 161
  • [4] Decreased expression of KLF6 and its significance in gastric carcinoma
    Qing Zhang
    Xiao-ping Tan
    Yue-sha Yuan
    Cheng-ming Hu
    Chang-hua He
    Wei-zheng Wang
    Jun-chuan Li
    Qiu Zhao
    Nan-zhi Liu
    Medical Oncology, 2010, 27 : 1295 - 1302
  • [5] The role of KLF6 and its splice variants in cancer therapy
    DiFeo, Analisa
    Martignetti, John A.
    Narla, Goutham
    DRUG RESISTANCE UPDATES, 2009, 12 (1-2) : 1 - 7
  • [6] Decreased expression of KLF6 and its significance in gastric carcinoma
    Zhang, Qing
    Tan, Xiao-ping
    Yuan, Yue-sha
    Hu, Cheng-ming
    He, Chang-hua
    Wang, Wei-zheng
    Li, Jun-chuan
    Zhao, Qiu
    Liu, Nan-zhi
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1295 - 1302
  • [7] KLF6 is a tumor suppressor gene that is lost and/or mutated in a majority of HCC.
    Tal-Kremer, S
    Reeves, HL
    Cooreman, MP
    Thung, S
    Schwartz, M
    Bruix, J
    Walewski, JL
    Eng, F
    Martignetti, JA
    Friedman, SL
    HEPATOLOGY, 2002, 36 (04) : 394A - 394A
  • [8] E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor
    A DiFeo
    G Narla
    O Camacho-Vanegas
    H Nishio
    S L Rose
    R E Buller
    S L Friedman
    M J Walsh
    J A Martignetti
    Oncogene, 2006, 25 : 6026 - 6031
  • [9] Post-transcriptional activation of PPM alpha by KLF6 in hepatic steatosis
    Bechmann, Lars P.
    Vetter, Diana
    Ishida, Junichi
    Hannivoort, Rebekka A.
    Lang, Ursula E.
    Kocabayoglu, Peri
    Fiel, M. Isabel
    Munoz, Ursula
    Patman, Gillian L.
    Ge, Fengxia
    Yakar, Shoshana
    Li, Xiaosong
    Agius, Loranne
    Lee, Young-Min
    Zhang, Weijia
    Hui, Kei Yiu
    Televantou, Despina
    Schwartz, Gary J.
    LeRoith, Derek
    Berk, Paul D.
    Nagai, Ryozo
    Suzuki, Toru
    Reeves, Helen L.
    Friedman, Scott L.
    JOURNAL OF HEPATOLOGY, 2013, 58 (05) : 1000 - 1006
  • [10] E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor
    DiFeo, A.
    Narla, G.
    Camacho-Vanegas, O.
    Nishio, H.
    Rose, S. L.
    Buller, R. E.
    Friedman, S. L.
    Walsh, M. J.
    Martignetti, J. A.
    ONCOGENE, 2006, 25 (44) : 6026 - 6031
12345